A detailed history of Rock Springs Capital Management LP transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 1,179,740 shares of AUPH stock, worth $10.7 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
1,179,740
Previous 1,179,740 -0.0%
Holding current value
$10.7 Million
Previous $6.74 Million 28.37%
% of portfolio
0.29%
Previous 0.21%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.81 - $5.78 $141,380 - $169,891
29,393 Added 2.56%
1,179,740 $6.74 Million
Q1 2024

May 15, 2024

BUY
$4.93 - $9.31 $3.64 Million - $6.87 Million
737,777 Added 178.82%
1,150,347 $5.76 Million
Q4 2023

Feb 14, 2024

SELL
$7.13 - $9.49 $477,496 - $635,545
-66,970 Reduced 13.97%
412,570 $3.71 Million
Q4 2022

Feb 14, 2023

SELL
$4.11 - $8.14 $2.41 Million - $4.78 Million
-586,868 Reduced 55.03%
479,540 $2.07 Million
Q3 2022

Nov 14, 2022

BUY
$6.66 - $12.39 $1.67 Million - $3.11 Million
251,282 Added 30.83%
1,066,408 $8.02 Million
Q2 2022

Aug 15, 2022

BUY
$8.95 - $12.8 $394,766 - $564,582
44,108 Added 5.72%
815,126 $8.19 Million
Q1 2022

May 16, 2022

BUY
$10.05 - $22.48 $3.15 Million - $7.06 Million
313,845 Added 68.65%
771,018 $9.55 Million
Q4 2021

Feb 14, 2022

SELL
$17.78 - $33.08 $2.78 Million - $5.16 Million
-156,096 Reduced 25.45%
457,173 $10.5 Million
Q3 2021

Nov 15, 2021

SELL
$10.93 - $23.55 $1.89 Million - $4.06 Million
-172,500 Reduced 21.95%
613,269 $13.6 Million
Q2 2021

Aug 16, 2021

BUY
$10.0 - $14.52 $42,000 - $60,984
4,200 Added 0.54%
785,769 $10.2 Million
Q1 2021

May 17, 2021

BUY
$12.3 - $18.73 $97,170 - $147,967
7,900 Added 1.02%
781,569 $10.1 Million
Q4 2020

Feb 16, 2021

BUY
$12.94 - $16.05 $14,234 - $17,655
1,100 Added 0.14%
773,669 $10.7 Million
Q3 2020

Nov 16, 2020

BUY
$13.19 - $16.66 $10.2 Million - $12.9 Million
772,569 New
772,569 $11.4 Million

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.29B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.